Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,767,364,935
-
Number of holders
-
2,657
-
Total 13F shares, excl. options
-
1,182,050,895
-
Shares change
-
-5,951,003
-
Total reported value, excl. options
-
$133,115,260,852
-
Value change
-
-$647,210,591
-
Put/Call ratio
-
101%
-
Number of buys
-
1,395
-
Number of sells
-
-967
-
Price
-
$112.64
Significant Holders of AbbVie Inc. - Common Stock (ABBV) as of Q2 2021
2,817 filings reported holding ABBV - AbbVie Inc. - Common Stock as of Q2 2021.
AbbVie Inc. - Common Stock (ABBV) has 2,657 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,182,050,895 shares
of 1,767,364,935 outstanding shares and own 66.9% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (144,693,566 shares), BlackRock Inc. (122,591,994 shares), STATE STREET CORP (75,963,304 shares), FMR LLC (35,456,978 shares), JPMORGAN CHASE & CO (34,960,994 shares), PRICE T ROWE ASSOCIATES INC /MD/ (28,999,335 shares), GEODE CAPITAL MANAGEMENT, LLC (27,244,949 shares), NORTHERN TRUST CORP (22,654,637 shares), Bank of New York Mellon Corp (20,995,513 shares), and Berkshire Hathaway Inc (20,527,861 shares).
This table shows the top 2,657 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.